Ozurdex completely located inside a crystallized lens - Results of 14 months

Am J Ophthalmol Case Rep. 2016 Aug 11:4:38-40. doi: 10.1016/j.ajoc.2016.08.001. eCollection 2016 Dec.

Abstract

Purpose: To report the therapeutic efficacy and results of an accidentally injected intralenticular sustained-release dexamethasone implant (Ozurdex) in a patient with macular edema secondary to central retinal vein occlusion at 14 months after injection.

Observations: We present a 70-year-old female patient with central retinal vein occlusion who underwent an Ozurdex injection. Patient discontinued from the treatment period during the 14-month and there was no ophthalmologic examination of the patient. Detailed ophthalmological examination was performed. Ozurdex localization was determined by Pentacam rotating Scheimpflug System. The implant was accidentally injected into the crystalline lens. It did not cause a totally lens opacification but did result only in a posterior subcapsular cataract. The macular edema did not resolve, and the patient underwent phacoemulsification surgery.

Conclusions and importance: Ozurdex that totally located inside the crystallize lens may not have the therapeutic effects.

Keywords: Intralenticular dexamethasone implant; Macular edema; Ozurdex; Retinal vein occlusion.

Publication types

  • Case Reports